Listed by the USPTO as MINCHELLA, KAITLYN L
Tech Center 1600 • Art Units: 1631 1672 1682 1685
This examiner grants 26% of resolved cases
MINCHELLA, KAITLYN L handles cases in tech center 1600 and art unit 1631. The profile reports 163 resolved cases and an allowance rate of 26.4%. The median time to allowance is 1595 days. Interview lift is 21.7%, so interviews are associated with a higher allowance result than the profile's overall case history.
Named companies include Tempus AI Inc., The Johns Hopkins University, and University of Maryland, Baltimore. Named firms include Fox Rothschild LLP - JHU, LEYDIG VOIT & MAYER, LTD, and Nevrivy Patent Law Group P.L.L.C. The combination of the allowance rate and median duration supports careful claim development and early attention to prosecution timing.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17186816 | METHOD FOR VERIFYING CULTIVATION DEVICE PERFORMANCE | Non-Final OA | Hoffmann-La Roche Inc. |
| 18118528 | Classifying User Activity Using Multiple Sensors | Final Rejection | Samsung Electronics Co., Ltd. |
| 18035067 | NETWORK APPROACH TO NAVIGATING THE HUMAN GENOME | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF MICHIGAN |
| 19341734 | PLATFORMS, SYSTEMS, AND METHODS FOR PATHWAY OPTIMIZATION FOR PROCESS BOTTLENECKS IN SYNTHETIC BIOLOGY DEVELOPMENT | Non-Final OA | X Development LLC |
| 17629327 | DETECTING NEURALLY PROGRAMMED TUMORS USING EXPRESSION DATA | Final Rejection | Genentech, Inc. |
| 17842893 | CELL-FREE DNA FOR ASSESSING AND/OR TREATING CANCER | Final Rejection | The Johns Hopkins University |
| 17204892 | CELL-FREE DNA FOR ASSESSING AND/OR TREATING CANCER | Final Rejection | The Johns Hopkins University |
| 17745399 | NANOPORE SENSOR FOR ENZYME-MEDIATED PROTEIN TRANSLOCATION | Final Rejection | The Regents of the University of California |
| 17571412 | SYSTEMS AND METHODS FOR JOINT LOW-COVERAGE WHOLE GENOME SEQUENCING AND WHOLE EXOME SEQUENCING INFERENCE OF COPY NUMBER VARIATION FOR CLINICAL DIAGNOSTICS | Final Rejection | Tempus AI, Inc. |
| 17150992 | SYSTEMS AND METHODS FOR MULTI-LABEL CANCER CLASSIFICATION | Final Rejection | Tempus AI, Inc. |
| 16732229 | TRANSCRIPTOME DECONVOLUTION OF METASTATIC TISSUE SAMPLES | Final Rejection | TEMPUS AI, INC. |
| 17759734 | METHOD AND COMPOSITION FOR MICROBIOME BASED AMELIORATION OF SKIN ASSOCIATED AUTOIMMUNE INFLAMMATORY DISEASES | Non-Final OA | Tata Consultancy Services Limited |
| 18555972 | ANALYSIS METHOD OF BASE SEQUENCE AND GENE ANALYZER | Non-Final OA | Hitachi High-Tech Corporation |
| 17773031 | METHOD FOR IDENTIFYING TRANSPLANT DONORS FOR A TRANSPLANT RECIPIENT | Final Rejection | CareDx, Inc. |
| 16666210 | HIGHLY SENSITIVE TRANSPLANT REJECTION SURVEILLANCE USING TARGETED DETECTION OF DONOR SPECIFIC CELL FREE DNA | Non-Final OA | The Medical College of Wisconsin, Inc |
| 17590659 | System, Method and Computer Simulation Environment For In Silico Trials in Pre-Diabetes and Type 2 Diabetes | Final Rejection | University of Virginia Patent Foundation |
| 18401532 | DETECTION DEVICE AND DETECTION METHOD | Final Rejection | SHIMADZU CORPORATION |
| 18556328 | MACHINE LEARNING BASED HISTOPATHOLOGICAL RECURRENCE PREDICTION MODELS FOR HPV+ HEAD / NECK SQUAMOUS CELL CARCINOMA | Non-Final OA | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
| 18007725 | METHODS AND SOFTWARE SYSTEMS TO OPTIMIZE AND PERSONALIZE THE FREQUENCY OF CANCER SCREENING BLOOD TESTS | Final Rejection | 20/20 GeneSystems |
| 17613966 | SIMULATION OF TEMPERATURES IN THE BODY | Final Rejection | ELMEDIX NV |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy26.4% of resolved applications examined by Kaitlyn L Minchella were allowed (163 resolved cases), compared with 28.4% across Art Unit 1631 over the last five years.
This examiner's interview lift is +21.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Kaitlyn L Minchella took 1,595 days on average from filing to allowance.
Kaitlyn L Minchella examines applications in Art Unit 1631 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
